Rare diseases
Investigational molecules
Locations
10578 Science Center Drive Suite 250, 92121-1147, United States
Escient Pharmaceuticals Inc. is active in clinical research focused on chronic spontaneous urticaria and chronic inducible urticaria, with studies centered on symptoms driven by persistent wheals, itching, and trigger-related skin reactions.
The sponsor’s trial portfolio reflects interest in immune-mediated skin disorders and the clinical management of urticaria symptoms across different disease patterns.
Escient Pharmaceuticals Inc. runs clinical trials in conditions such as Chronic spontaneous urticaria, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
